Form4insider filings, from the source

SEC Form 4 · accession 0001615219-16-000230

Decoy Therapeutics Inc. · DCOY

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Christoph H Westphal
Officer — President and CEO · Director · 10% Owner
Period of report
Nov 7, 2016
Accepted (ET)
Nov 7, 2016 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001615219

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 7, 2016P8,870$5.70A3,934,118D
Common StockF2holding———3,212,861ISee notes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses